Autopsy report · NCT00874497

Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema

“Sponsor Terminated”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 years 5 months before it stopped.
• 84 participants enrolled.
• Results were posted on the registry 1 year 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Sponsor type

Industry

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

tetomilast; placebo

Participants

84

Sites

15

Countries

United States

Trials that died the same way

• A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
  “Terminated by sponsor” (96% match in meaning)
• Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
  “Terminated by previous Sponsor decision” (90% match in meaning)
• ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
  “Terminated - Sponsor Decision” (90% match in meaning)
• Evaluation of Cranioplasty Using Native Bone Autograft Versus Synthetic Bone Allograft
  “Sponsor termination” (90% match in meaning)
• Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis
  “Sponsor requested termination” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.